Search scope:
排序: Display mode:
FGF23 associated bone diseases
Eryuan Liao
Frontiers of Medicine 2013, Volume 7, Issue 1, Pages 65-80 doi: 10.1007/s11684-013-0254-6
Recently, fibroblast growth factor 23 (FGF23) has sparked widespread interest because of its potentialIn this review, we summarized the FGF superfamily, the mechanism of FGF23 on phosphate and vitamin Dmetabolism, and the FGF23 related bone disease.
Keywords: fibroblast growth factor 23 FGF receptor phosphate metabolism Klotho bone disease
Xiaokun Li
Frontiers of Medicine 2019, Volume 13, Issue 5, Pages 511-530 doi: 10.1007/s11684-019-0711-y
Keywords: FGF19 FGF21 FGF23 FGFR metabolism endocrine Klotho
FGF13 suppresses acute myeloid leukemia by regulating bone marrow niches
Frontiers of Medicine 2022, Volume 16, Issue 6, Pages 896-908 doi: 10.1007/s11684-022-0944-z
Keywords: acute myeloid leukemia FGF13 prognosis immune-related genes bone marrow niches
Influence of retinoic acid on TBX1 expression in myocardial cells induced by Shh and Fgf8
Miao LIU, Xiaoyan WU, Jiawei XU, Runming JIN
Frontiers of Medicine 2009, Volume 3, Issue 1, Pages 61-66 doi: 10.1007/s11684-009-0007-8
Keywords: retinoic acid Tbx1 protein Shh protein Fgf8 protein
Nicotinic acetylcholine receptor α7 subunit: a novel therapeutic target for cardiovascular diseases
Chong Liu, Dingfeng Su
Frontiers of Medicine 2012, Volume 6, Issue 1, Pages 35-40 doi: 10.1007/s11684-012-0171-0
Keywords: α7 nicotinic acetylcholine receptor cardiovascular diseases baroreflex sensitivity
Frontiers of Medicine doi: 10.1007/s11684-024-1067-5
Keywords: response nucleic acids
Peter B. Alexander,Xiao-Fan Wang
Frontiers of Medicine 2015, Volume 9, Issue 2, Pages 134-138 doi: 10.1007/s11684-015-0396-9
Keywords: targeted therapy drug resistance receptor tyrosine kinases cancer
Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology
Huating Li, Jing Zhang, Weiping Jia
Frontiers of Medicine 2013, Volume 7, Issue 1, Pages 25-30 doi: 10.1007/s11684-013-0244-8
Fibroblast growth factor 21 (FGF21) is a member of the fibroblast growth factor family.It is demonstrated that FGF21 acts on multiple tissue to coordinate carbohydrate and lipid metabolismMoreover, FGF21 also plays important roles in some physiological processes, such as fasting and feedingClinical relevance of FGF21 in humans is still unclear, and the basis and consequences of increased FGF21This article concentrates on recent advances in our understanding of FGF21.
Keywords: FGF21 metabolism pharmacology physiology clinical relevance
Wenjie Zhu, Binghe Xu
Frontiers of Medicine 2021, Volume 15, Issue 2, Pages 208-220 doi: 10.1007/s11684-020-0795-4
Keywords: endocrine-resistant HR+/HER2- advanced breast cancer randomized clinical trials meta-analysis targeted therapy
Chimeric antigen receptor T cell targeting EGFRvIII for metastatic lung cancer therapy
Zhao Zhang, Jun Jiang, Xiaodong Wu, Mengyao Zhang, Dan Luo, Renyu Zhang, Shiyou Li, Youwen He, Huijie Bian, Zhinan Chen
Frontiers of Medicine 2019, Volume 13, Issue 1, Pages 57-68 doi: 10.1007/s11684-019-0683-y
Keywords: chimeric antigen receptor T cells epidermal growth factor receptor lung cancer immunotherapy tumor immunolog
Changlin Cao, Jingxian Gu, Jingyao Zhang
Frontiers of Medicine 2017, Volume 11, Issue 2, Pages 169-177 doi: 10.1007/s11684-017-0505-z
Keywords: soluble triggering receptor expressed on myeloid cells-1 infectious diseases diagnosis and prognosis
Chimeric antigen receptor T cell therapies for acute myeloid leukemia
Bin Gu, Jianhong Chu, Depei Wu
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 701-710 doi: 10.1007/s11684-020-0763-z
Keywords: acute myeloid leukemia CAR T immunotherapy
Frontiers of Medicine 2023, Volume 17, Issue 4, Pages 699-713 doi: 10.1007/s11684-022-0972-8
Keywords: anti-CD19 chimeric antigen receptor T immunotherapy diffuse large B cell lymphoma tumor microenvironment
Blockage of receptor-interacting protein 2 expression by small interfering RNA in murine macrophages
LIU Hongchun, CAO Zhongwei, JIN Jianjun, WANG Jiyao
Frontiers of Medicine 2008, Volume 2, Issue 2, Pages 166-170 doi: 10.1007/s11684-008-0030-1
Quan LI MD , Weiming LI MD , Ping ZOU MD , Jian ZHANG BM ,
Frontiers of Medicine 2009, Volume 3, Issue 3, Pages 309-315 doi: 10.1007/s11684-009-0043-4
Keywords: graft vs host disease proteinase-activated receptor murine model hematopoietic stem cell transplantation
Title Author Date Type Operation
Influence of retinoic acid on TBX1 expression in myocardial cells induced by Shh and Fgf8
Miao LIU, Xiaoyan WU, Jiawei XU, Runming JIN
Journal Article
Nicotinic acetylcholine receptor α7 subunit: a novel therapeutic target for cardiovascular diseases
Chong Liu, Dingfeng Su
Journal Article
Adenosine deaminase 2 regulates the activation of the Toll-like receptor 9 in response to nucleic acids
Journal Article
Resistance to receptor tyrosine kinase inhibition in cancer: molecular mechanisms and therapeutic strategies
Peter B. Alexander,Xiao-Fan Wang
Journal Article
Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology
Huating Li, Jing Zhang, Weiping Jia
Journal Article
Overcoming resistance to endocrine therapy in hormone receptor-positive human epidermal growth factorreceptor 2-negative (HR
Wenjie Zhu, Binghe Xu
Journal Article
Chimeric antigen receptor T cell targeting EGFRvIII for metastatic lung cancer therapy
Zhao Zhang, Jun Jiang, Xiaodong Wu, Mengyao Zhang, Dan Luo, Renyu Zhang, Shiyou Li, Youwen He, Huijie Bian, Zhinan Chen
Journal Article
Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a potential biomarker for the diagnosis
Changlin Cao, Jingxian Gu, Jingyao Zhang
Journal Article
Chimeric antigen receptor T cell therapies for acute myeloid leukemia
Bin Gu, Jianhong Chu, Depei Wu
Journal Article
microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor
Journal Article
Blockage of receptor-interacting protein 2 expression by small interfering RNA in murine macrophages
LIU Hongchun, CAO Zhongwei, JIN Jianjun, WANG Jiyao
Journal Article